Abstract: A filter assembly for a diesel particulate filter is provided, the filter assembly having: a first end disk; a second end disk; a center tube secured to the first end disk by a sealing glass; a filter media secured to the first end disk and the second end disk by a sealing glass.

Abstract: A filter assembly for a diesel particulate filter, the filter assembly having: a first end disk; a second end disk; a center tube secured to the first end disk by a sealing glass; a filter media secured to the first end disk and the second end disk by a sealing glass.

Abstract: A filter assembly for a diesel particulate filter, the filter assembly having: a first end disk; a second end disk; a center tube secured to the first end disk by a sealing glass; a filter media secured to the first end disk and the second end disk by a sealing glass.

Abstract: Novel derivatives of prostaglandin compounds of the F-series (PGF), specifically macrocyclic internal 1,15-lactones of fluprostenol and related PGF analogs, such as cloprostenol or latanoprost. The novel analogs can be formulated into ophthalmic solutions and topically applied for the treatment of the increased intraocular pressure caused by glaucoma and the reduction of ocular hypertension.

Abstract: Methods, compositions and kits are provided for measuring aspirin's anti-thrombotic effectiveness on a subject. Included are a novel assay for quickly and specifically measuring TxA2 metabolite levels in urine and correlating the levels with aspirin dose in a subject. The methods, compositions and kits utilize a novel anti TxA2 metabolite antibody.

Abstract: Disclosed are systems and methods for providing expedited, unlimited, unrestricted, free or minimal cost access to information such as scientific research results. The methods and systems include receiving information, identifying at least one product included in the received information, retrieving links associated with the identified product or products, publishing the received information and the retrieved links, and receiving revenue from the entities associated with the identified products. A portion of the received revenue is then expended on one or more of the costs of providing access to the received information. In one aspect of the invention, information is received and provided via the Internet, advertising links are provided in the form of thumbnail images, and revenue is generated for each click of a thumbnail image.

Abstract: An ophthalmic formulation for the treatment of glaucoma and intraocular pressure with a prostaglandin compound of the F-series (PGF), and particularly a prodrug form of a PGF2? analog, such as an ester, amide, or internal lactone, wherein preservative is an antimicrobial peptide, such as lactoferrin. In particularly preferred embodiments, the prostaglandin compound is a macrocyclic internal 1,15-lactone, such as the 16-aryloxy prostaglandin analogs, illustratively fluprostenol or cloprstenol.

Abstract: Novel derivatives of prostaglandin compounds of the F-series (PGF), specifically macrocyclic internal 1,15-lactones of fluprostenol and related PGF analogs, such as cloprostenol or latanoprost. The novel analogs can be formulated into ophthalmic solutions and topically applied for the treatment of the increased intraocular pressure caused by glaucoma and the reduction of ocular hypertension.